Preprocedural high-sensitivity cardiac Troponin T and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention

Circulation: Cardiovascular Interventions

Volumn 9, Issue 6, 2016, Pages

  Zanchin, Thomas ^a   Räber, Lorenz ^a   Koskinas, Konstantinos C ^a   Piccolo, Raffaele ^a   Jüni, Peter ^b   Pilgrim, Thomas ^a   Stortecky, Stefan ^a   Khattab, Ahmed A ^a   Wenaweser, Peter ^a   Bloechlinger, Stefan ^a   Moschovitis, Aris ^a   Frenk, Andre ^a   Moro, Christina ^a   Meier, Bernhard ^a   Fiedler, Georg M ^a   Heg, Dik ^c   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

all cause death; coronary intervention; percutaneous coronary intervention; prognosis; stable coronary artery disease; troponin T

Indexed keywords

TROPONIN T; BIOLOGICAL MARKER; TNNT2 PROTEIN, HUMAN;

ARTICLE; CORONARY ARTERY DISEASE; ELECTIVE PERCUTANEOUS CORONARY INTERVENTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORTALITY; MORTALITY RISK; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK; RISK FACTOR; STABLE CORONARY ARTERY DISEASE; AGED; BLOOD; CAUSE OF DEATH; DEVICES; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; FEMALE; MALE; MIDDLE AGED; PREDICTIVE VALUE; RISK ASSESSMENT; SWITZERLAND; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T; UP-REGULATION;

EID: 84975690651     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.003202     Document Type: Article

References (34)

1. de Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA. 2013; 309: 2262-2269. doi: 10.1001/jama.2013.5809
2. Cantor WJ, Newby LK, Christenson RH, Tuttle RH, Hasselblad V, Armstrong PW, Moliterno DJ, Califf RM, Topol EJ, Ohman EM; SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol. 2002; 39: 1738-1744
3. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR Jr, Rihal CS. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-Term mortality. J Am Coll Cardiol. 2006; 48: 1765-1770. doi: 10.1016/j.jacc.2006.04.102
4. Kizer JR, Muttrej MR, Matthai WH, McConnell J, Nardone H, Sonel AF, Keane MG, Wilensky RL. Role of cardiac troponin T in the long-Term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J. 2003; 24: 1314-1322
5. Miller WL, Garratt KN, Burritt MF, Lennon RJ, Reeder GS, Jaffe AS. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J. 2006; 27: 1061-1069. doi: 10.1093/eurheartj/ehi760
6. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008; 1: 10-19. doi: 10.1161/CIRCINTERVENTIONS.108.765610
7. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, Giannitsis E, Katus HA. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart. 2011; 97: 823-831. doi: 10.1136/hrt.2010.193201
8. Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, Leiner T, Wildberger JE, Narula J, Van Dieijen-Visser MP, Hofstra L. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol. 2010; 30: 1269-1275. doi: 10.1161/ATVBAHA.109.200394
9. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014; 35: 2541-2619
10. Vranckx P, Kalesan B, Stefanini GG, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys PW, Windecker S. Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. EuroIntervention. 2015; 11: 171-179. doi: 10.4244/EIJV11I2A31
11. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009; 361: 2538-2547. doi: 10.1056/NEJMoa0805299
12. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, R'sj' H, šaltyte Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E; PEACE Investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013; 61: 1240-1249. doi: 10.1016/j. jacc.2012.12.026
13. Koskinas KC, Räber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blöchlinger S, Moro C, Jüni P, Meier B, Heg D, Windecker S. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv. 2015; 8: e002053. doi: 10.1161/CIRCINTERVENTIONS.114.002053
14. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34: 2949-3003
15. Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, Serruys PW. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention. 2010; 5: 871-874
16. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010; 56: 254-261. doi: 10.1373/clinchem.2009.132654
17. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007; 115: 2344-2351. doi: 10.1161/CIRCULATIONAHA.106.685313
18. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011; 123: 2736-2747. doi: 10.1161/CIRCULATIONAHA.110.009449
19. Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ; Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008; 118: 632-638. doi: 10.1161/CIRCULATIONAHA.107.752428
20. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA. Age-And sex-dependent upper reference limits for the highsensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014; 63: 1441-1448. doi: 10.1016/j.jacc.2013.12.032
21. Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009; 54: 477-486. doi: 10.1016/j.jacc.2009.03.063
22. Haaf P, Reichlin T, Twerenbold R, Hoeller R, Rubini Gimenez M, Zellweger C, Moehring B, Fischer C, Meller B, Wildi K, Freese M, Stelzig C, Mosimann T, Reiter M, Mueller M, Hochgruber T, Sou SM, Murray K, Minners J, Freidank H, Osswald S, Mueller C. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J. 2014; 35: 365-375. doi: 10.1093/eurheartj/eht218
23. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010; 304: 2503-2512. doi: 10.1001/jama.2010.1768
24. Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S. Highsensitivity cardiac troponin I and B-Type natriuretic peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 2015; 131: 1851-1860. doi: 10.1161/CIRCULATIONAHA.114.014522
25. Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group. Troponin and cardiac events in stable ischemic heart disease and diabetes. N Engl J Med. 2015; 373: 610-620. doi: 10.1056/NEJMoa1415921
26. Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, Hoogeveen RC, Sharrett AR, Ballantyne CM, Coresh J. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation. 2014; 130: 1374-1382. doi: 10.1161/CIRCULATIONAHA.114.010815
27. Everett BM, Cook NR, Magnone MC, Bobadilla M, Kim E, Rifai N, Ridker PM, Pradhan AD. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation. 2011; 123: 2811-2818. doi: 10.1161/CIRCULATIONAHA.110.009928
28. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991; 67: 1360-1367
29. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001; 103: 934-940
30. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999; 82: 265-268
31. Suleiman MS, Lucchetti V, Caputo M, Angelini GD. Short periods of regional ischaemia and reperfusion provoke release of troponin I from the human hearts. Clin Chim Acta. 1999; 284: 25-30
32. Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J. 2009; 30: 162-169. doi: 10.1093/eurheartj/ehn504
33. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons ML. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999; 340: 1623-1629. doi: 10.1056/NEJM199905273402103
34. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E; TACTICS (Treat Angina With Aggrastat and Determine Cost of Therapy With an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001; 344: 1879-1887. doi: 10.1056/NEJM200106213442501